TO1.R4: Technological Advances in Ultrasound Contrast Agents |
| Session Type: Lecture |
| Time: Tuesday, June 30, 10:45 - 12:05 |
| Location: Stanbro |
| TO1.R4.1: TARGETED DRUG DELIVERY IN THE BRAIN VIA ULTRASOUND-INDUCED BLOOD-BRAIN BARRIER DISRUPTION |
| Nathan McDannold; Brigham & Women's Hospital, Harvard Medical School |
| Lisa Treat; Brigham & Women's Hospital, Harvard Medical School / Massachusetts Institute of Technology |
| Natalia Vykhodtseva; Brigham & Women's Hospital, Harvard Medical School |
| Kullervo Hynynen; University of Toronto, Sunnybrook Health Sciences Centre |
| TO1.R4.2: IMPROVING TECHNOLOGY FOR MOLECULAR IMAGING WITH ULTRASOUND |
| Paul A. Dayton; University of North Carolina-North Carolina State University |
| TO1.R4.3: FDA PERSPECTIVE ON ULTRASOUND CONTRAST AGENTS SAFETY AND DEVELOPMENT |
| Ira Krefting; U.S. Food and Drug Administration |
| TO1.R4.4: ECHOGENIC LIPSOMES FOR TARGETED DRUG DELIVERY |
| Christy K. Holland; University of Cincinnati |
| David D. McPherson; University of Texas Health Science Center |